Market News & Trends
Cleveland BioLabs & Incuron Announce Orphan Drug Status
Cleveland BioLabs, Inc. and Incuron, LLC, a joint venture between the company and Bioprocess Capital Ventures, recently announced that curaxin CBL0102 (quinacrine) has been granted…
Mayne Pharma Announces Major Acquisition
Mayne Pharma Group Limited recently announce it has entered into a binding agreement to acquire Metrics, Inc. Consideration for the acquisition will comprise an up-front…
Patheon Launches Innovative Meet the Experts Program
Patheon Inc. recently announced the launch of its new Meet the Experts program. The program provides direct access to scientific and technical experts, both from…
Hovione Expands Offering to Solve Bioavailability & Other Delivery Challenges
Hovione recently announced the expansion of its solutions to solve issues of poor bioavailability, patient acceptability, and the enabling of optimal delivery for non-oral routes…
Kinexum & Pennington Biomedical Announce Collaboration
Kinexum and Pennington Biomedical Research Center recently announced plans to establish an integrated approach for emerging companies and early stage therapies to achieve high-value regulatory…
Theorem Clinical Research Expands Service Area Worldwide
To help bring life-saving drugs to market around the world, Theorem Clinical Research Inc. offers Theorem Strategic Sourcing Solutions to provide staffing and outsourcing services…
10/3/2012
Actinium Announces Multi-Million Financing Actinium Pharmaceuticals, Inc. recently announced it has engaged Laidlaw & Company (UK) Ltd. and launched a new round of fundraising that…
Actinium Announces Multi-Million Financing
Actinium Pharmaceuticals, Inc. recently announced it has engaged Laidlaw & Company (UK) Ltd. and launched a new round of fundraising that will culminate in a…
Clinipace Worldwide Buys Paragon Biomedical; Plans New Hires
Clinipace Worldwide and Paragon Biomedical, Inc. recently announced a definitive merger agreement under which Clinipace Worldwide has acquired all outstanding shares of the privately held,…
Covidien's Mallinckrodt to Acquire Company for $100 Million
Mallinckrodt, the Pharmaceuticals business of Covidien, recently announced a definitive agreement to acquire CNS Therapeutics, Inc. Mallinckrodt will acquire all of the outstanding capital stock…
9/25/2012
BD Introduces Shortest, Thinnest Pen Needle Studies suggest that as many as one-fifth to one-third of people with diabetes are hesitant or unwilling to…
BD Introduces Shortest, Thinnest Pen Needle
Studies suggest that as many as one-fifth to one-third of people with diabetes are hesitant or unwilling to give themselves insulin injections for reasons that…
Catalent Completes $350-Million Offering
Catalent Pharma Solutions, Inc. recently announced the successful completion of its $350-million offering of 7.875% Senior Notes due 2018, issued at par. Catalent has used…
JHP Pharmaceuticals to Produce Lyophilized Biologic
JHP Pharmaceuticals recently announced it has entered into an agreement with an undisclosed pharmaceutical company to produce supplies of a lyophilized biologic for international, late-phase…
Jubilant HollisterStier Launches Analytical Services Division
Jubilant HollisterStier, a subsidiary of Jubilant Life Sciences, recently announced that its Contract Manufacturing & Services division has launched an analytical services unit that will…
Selexys Completes Equity Financing & Signs Major Agreement
Selexys Pharmaceuticals, Corp. recently announced it has successfully completed a $23-million Series A equity financing, led by MPM Capital. Additionally, Selexys entered into an agreement…
SteadyMed Therapeutics Raises $10.4 Million
SteadyMed Therapeutics Inc., a drug delivery therapeutics company, recently announced it has raised $10.4 million in a private placement of preferred stock. Proceeds from the…
Xcelience Opens New Development Facility
Xcelience LLC recently announced the grand opening of a new 24,000-sq-ft facility, located south of the Tampa airport at 4901 Grace Street. The building will…
9/19/2012
PharmaTelevision Spotlights Aptalis' Year in Review FDA approvals, revenue gain, and organic business growth are just a few of the topics that John Fraher, President,…
Catalent & CTC Bio to Help Korean Pharma Enter New Markets
Catalent Pharma Solutions and CTC Bio have entered into a collaboration to provide optimal solutions to South Korean pharmaceutical companies seeking to commercialize solid oral…
